HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hua Xie Selected Research

Naphthyridines

11/2012Repositioning HIV-1 integrase inhibitors for cancer therapeutics: 1,6-naphthyridine-7-carboxamide as a promising scaffold with drug-like properties.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Hua Xie Research Topics

Disease

58Neoplasms (Cancer)
12/2022 - 08/2003
13Asthma (Bronchial Asthma)
02/2022 - 06/2003
13Hirschsprung Disease (Hirschsprung's Disease)
01/2020 - 05/2015
12Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
12/2022 - 01/2013
9Inflammation (Inflammations)
10/2022 - 01/2003
9Neoplasm Metastasis (Metastasis)
01/2022 - 06/2008
8Wounds and Injuries (Trauma)
09/2017 - 01/2006
7Hemorrhage
01/2022 - 05/2002
6Hypospadias
09/2021 - 06/2017
6Stomach Neoplasms (Stomach Cancer)
01/2020 - 03/2012
6Type 2 Diabetes Mellitus (MODY)
01/2018 - 01/2014
6Hypoxia (Hypoxemia)
01/2018 - 01/2015
6Adenocarcinoma
01/2017 - 03/2009
5Hepatocellular Carcinoma (Hepatoma)
03/2022 - 10/2011
5Breast Neoplasms (Breast Cancer)
01/2022 - 01/2011
5Allergic Rhinitis
01/2021 - 10/2002
5Body Weight (Weight, Body)
01/2020 - 01/2013
5Fibrosis (Cirrhosis)
01/2020 - 02/2004
4Carcinogenesis
12/2022 - 05/2013
4Lung Neoplasms (Lung Cancer)
12/2021 - 12/2012
4Infections
08/2020 - 12/2012
4Neural Tube Defects (Exencephaly)
11/2013 - 06/2011
3Non-alcoholic Fatty Liver Disease
07/2022 - 01/2020
3Rhinitis
02/2022 - 04/2015
3Periodontitis
10/2020 - 09/2006
3Shock
01/2020 - 01/2018
3Osteoporosis
10/2019 - 08/2003
3Pancreatic Neoplasms (Pancreatic Cancer)
05/2017 - 01/2017
3Hypersensitivity (Allergy)
12/2016 - 06/2004
3Altitude Sickness (Mountain Sickness)
11/2016 - 01/2015
3Human Influenza (Influenza)
03/2015 - 10/2002
3Necrosis
06/2008 - 01/2004
3Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
05/2005 - 11/2004
3Colitis
02/2004 - 02/2004
2Autoimmune Diseases (Autoimmune Disease)
10/2022 - 10/2021
2Squamous Cell Carcinoma (Epidermoid Carcinoma)
10/2021 - 03/2018
2Cicatrix (Scar)
10/2021 - 09/2017
2Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
01/2021 - 03/2020

Drug/Important Bio-Agent (IBA)

17Pharmaceutical PreparationsIBA
12/2022 - 01/2003
9Phosphotransferases (Kinase)IBA
12/2022 - 11/2012
9Proteins (Proteins, Gene)FDA Link
01/2021 - 11/2010
7EnzymesIBA
01/2020 - 01/2006
7Tryptases (Tryptase)IBA
01/2016 - 01/2003
7Immunoglobulin E (IgE)IBA
04/2015 - 06/2003
6ErbB Receptors (EGF Receptor)IBA
12/2022 - 09/2009
6AllergensIBA
02/2022 - 11/2013
5Biological ProductsIBA
01/2022 - 10/2004
5Interleukin-18 (Interleukin 18)IBA
05/2018 - 03/2005
5Biomarkers (Surrogate Marker)IBA
01/2018 - 01/2013
4Circular RNAIBA
01/2022 - 01/2017
4Long Noncoding RNAIBA
07/2019 - 01/2016
4Messenger RNA (mRNA)IBA
01/2018 - 03/2009
4CytokinesIBA
11/2016 - 07/2013
4MicroRNAs (MicroRNA)IBA
01/2016 - 05/2015
4trioctyl phosphine oxide (TOPO)IBA
08/2014 - 09/2008
4Calcium IonophoresIBA
06/2004 - 02/2004
3Agammaglobulinaemia Tyrosine KinaseIBA
10/2022 - 04/2018
3ORALIT (ORS)IBA
12/2021 - 01/2018
3LipidsIBA
01/2020 - 02/2013
3Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA
01/2020 - 05/2014
3Competitive Endogenous RNAIBA
05/2019 - 01/2017
3Transcription Factors (Transcription Factor)IBA
03/2019 - 05/2013
3Protein Isoforms (Isoforms)IBA
03/2019 - 01/2016
3Hematoxylin (Haematoxylon)IBA
03/2019 - 07/2011
3Folic Acid (Vitamin M)FDA LinkGeneric
01/2019 - 03/2013
3Gefitinib (Iressa)FDA Link
12/2018 - 01/2013
3Carrier Proteins (Binding Protein)IBA
05/2018 - 01/2017
3Interleukin-18 ReceptorsIBA
05/2018 - 01/2017
3L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA
02/2018 - 01/2017
3Interleukin-8 (Interleukin 8)IBA
01/2018 - 10/2004
3Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2018 - 03/2009
3ElastinIBA
09/2017 - 01/2004
3CollagenIBA
09/2017 - 04/2007
3Phospholipids (Phosphatides)FDA LinkGeneric
04/2017 - 01/2014
3ImmunosorbentsIBA
12/2016 - 11/2010
3DNA (Deoxyribonucleic Acid)IBA
06/2013 - 09/2008
3Hemostatics (Antihemorrhagics)IBA
04/2009 - 01/2008
3ChitosanIBA
04/2009 - 01/2008
3anti-IgE antibodiesIBA
11/2004 - 09/2003
3Chymases (Chymase)IBA
10/2004 - 02/2004
2Protons (Proton)IBA
07/2022 - 01/2022
2osimertinibIBA
02/2022 - 01/2019
2Doxorubicin (Adriamycin)FDA LinkGeneric
01/2022 - 09/2019
2Interleukin-1 Receptor-Associated KinasesIBA
01/2021 - 03/2020
2RNA (Ribonucleic Acid)IBA
01/2021 - 08/2015
2Androgen Receptors (Androgen Receptor)IBA
10/2020 - 01/2020
2Glucose (Dextrose)FDA LinkGeneric
01/2020 - 02/2013
2SolutionsIBA
01/2020 - 01/2018
2Blood Glucose (Blood Sugar)IBA
01/2020 - 10/2019
2Insulin (Novolin)FDA Link
01/2020 - 07/2011
2AlloysIBA
01/2020 - 01/2018

Therapy/Procedure

28Therapeutics
10/2020 - 08/2008
8Drug Therapy (Chemotherapy)
01/2020 - 01/2013
4Oral Administration
02/2022 - 03/2016
3Immunotherapy
01/2021 - 11/2013
3Transplantation
12/2010 - 03/2009
2Lasers (Laser)
10/2021 - 10/2013
2Surgical Flaps
09/2021 - 06/2017
2Subcutaneous Injections
01/2021 - 09/2017
2Aftercare (After-Treatment)
01/2021 - 03/2009